742 related articles for article (PubMed ID: 11272141)
1. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
[TBL] [Abstract][Full Text] [Related]
2. Increased glucose sensitivity of stimulus-secretion coupling in islets from Psammomys obesus after diet induction of diabetes.
Pertusa JA; Nesher R; Kaiser N; Cerasi E; Henquin JC; Jonas JC
Diabetes; 2002 Aug; 51(8):2552-60. PubMed ID: 12145170
[TBL] [Abstract][Full Text] [Related]
3. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?
Hansen AM; Bödvarsdottir TB; Nordestgaard DN; Heller RS; Gotfredsen CF; Maedler K; Fels JJ; Holst JJ; Karlsen AE
Diabetologia; 2011 Jun; 54(6):1379-87. PubMed ID: 21347622
[TBL] [Abstract][Full Text] [Related]
5. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP.
Abdel-Halim SM; Guenifi A; Khan A; Larsson O; Berggren PO; Ostenson CG; Efendić S
Diabetes; 1996 Jul; 45(7):934-40. PubMed ID: 8666145
[TBL] [Abstract][Full Text] [Related]
6. Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes.
Nesher R; Gross DJ; Donath MY; Cerasi E; Kaiser N
Diabetes; 1999 Apr; 48(4):731-7. PubMed ID: 10102688
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes.
Donath MY; Gross DJ; Cerasi E; Kaiser N
Diabetes; 1999 Apr; 48(4):738-44. PubMed ID: 10102689
[TBL] [Abstract][Full Text] [Related]
8. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
Laychock SG
Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
[TBL] [Abstract][Full Text] [Related]
11. IPF1/PDX1 deficiency and beta-cell dysfunction in Psammomys obesus, an animal With type 2 diabetes.
Leibowitz G; Ferber S; Apelqvist A ; Edlund H; Gross DJ; Cerasi E; Melloul D; Kaiser N
Diabetes; 2001 Aug; 50(8):1799-806. PubMed ID: 11473041
[TBL] [Abstract][Full Text] [Related]
12. Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon.
Komatsu M; Sato Y; Yamada S; Yamauchi K; Hashizume K; Aizawa T
Diabetes; 2002 Feb; 51 Suppl 1():S29-32. PubMed ID: 11815454
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical investigation of insulin secretion by pancreatic beta-cells in control and diabetic Psammomys obesus.
Bendayan M; Malide D; Ziv E; Levy E; Ben-Sasson R; Kalman R; Bar-On H; Chrétien M; Seidah N
J Histochem Cytochem; 1995 Aug; 43(8):771-84. PubMed ID: 7622840
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
18. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
Uçkaya G; Delagrange P; Chavanieu A; Grassy G; Berthault MF; Ktorza A; Cerasi E; Leibowitz G; Kaiser N
J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
[TBL] [Abstract][Full Text] [Related]
19. Glucose-regulated proinsulin gene expression is required for adequate insulin production during chronic glucose exposure.
Leibowitz G; Uçkaya G; Oprescu AI; Cerasi E; Gross DJ; Kaiser N
Endocrinology; 2002 Sep; 143(9):3214-20. PubMed ID: 12193532
[TBL] [Abstract][Full Text] [Related]
20. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
Jimenez-Feltstrom J; Lundquist I; Salehi A
Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
